Open Ledger
Medtronic financials in Beancount
Medtronic keeps 5 recorded periods through FY2027Q1 as a balanced Beancount ledger — inspect the figures below, then open the live books.
Updated
Latest figures
- Revenue
- $9.8B (9,756 MUSD)
- Net income
- $1.5B (1,470 MUSD)
- Net margin
- 15.1%
Recorded history
| Period | Period end | Revenue | Net income |
|---|---|---|---|
FY2023 | April 28, 2023 | $31.2B (31,227 MUSD) | $3.8B (3,758 MUSD) |
FY2024 | April 26, 2024 | $32.4B (32,364 MUSD) | $3.7B (3,676 MUSD) |
FY2025 | April 25, 2025 | $33.5B (33,537 MUSD) | $4.7B (4,662 MUSD) |
FY2026 | April 24, 2026 | $36.4B (36,364 MUSD) | $4.8B (4,801 MUSD) |
Recorded revenue and net income in MUSD (Quarter periods).
| Period | Period end | Revenue | Net income |
|---|---|---|---|
FY2027Q1 | July 31, 2026 | $9.8B (9,756 MUSD) | $1.5B (1,470 MUSD) |
Coverage
Coverage5
FY2023FY2024FY2025FY2026FY2027Q1
Earnings analyses
More companies in this sector
- Hims HersHims & Hers Q2 2026 Earnings: Revenue Up 38% to $753M as GAAP Swings to an $86M Loss
- Novo NordiskNovo Nordisk H1 2026 Earnings: DKK 175.3B Sales, DKK 69.5B Net Profit, Outlook 'Raised' to 0% to −6%
- Eli LillyEli Lilly Q2 2026 Earnings: $12.2 Billion Quarter and $85–87 Billion Guide as GLP-1 Royalty Compounds